Venturis Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Venturis Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease (NCT00424866) | Venturis Therapeutics, Inc. | 2020-12-01 |
| Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease (NCT00117936) | Venturis Therapeutics, Inc. | 2020-03-01 |
Track Venturis Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.